This week was ruled by cancer data presentations by drug companies at the annual meeting of the American Association for Cancer Research (AACR) in Chicago. Other than that, J&J JNJand Novartis NVSkicked off 2018 pharma earnings on a strong note, beating the Zacks Consensus Estimate for both earnings and sales in the first quarter of 2018.
Pharma Stock Roundup: NVS, JNJ Q1 Sales & Earnings Top, MRK & BMY Active at AACR
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться